Perrigo's once-a-day Opill will be sold without a prescription and with no age restrictions on sales.
Nitrous oxide — or laughing gas — was commonly used during childbirth in the U.S. in the 1930s but with the emergence of epidurals, its popularity declined in the 1970s., which will let American women and girls buy contraceptive medication from the same aisle as aspirin and eyedrops.
Some of the challenges can include paying for a doctor's visit, getting time off from work and finding child care. FDA’s action only applies to Opill. It’s in an older class of contraceptives, sometimes called minipills, that contain a single synthetic hormone and generally carry fewer side effects than more popular combination hormone pills.
Dyvia Huitron was among those who presented, explaining how she has been unable to get prescription birth control more than three years after becoming sexually active. The 19-year-old University of Alabama student said she still isn’t comfortable getting a prescription because the school’s health system reports medical exams and medications to parents.
The groups helped fund some of the studies submitted for Opill and they encouraged HRA Pharma, later acquired by Perrigo, to file its application with the FDA.
Indonesia Berita Terbaru, Indonesia Berita utama
Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.
First over-the-counter birth control pill gets FDA approvalU.S. officials have approved the first over-the-counter birth control pill, which will let American women and girls buy contraceptive medication from the same aisle as aspirin and eyedrops. The Food and Drug Administration said Thursday it cleared Perrigo’s once-a-day Opill to be sold without a prescription, making it the first such medication to be moved out from behind the pharmacy counter. The company won’t start shipping the pill until early next year, and there will be no age restrictions on sales.
Baca lebih lajut »
FDA OKs Inclisiran, Added to Statins, for Primary PreventionThe FDA has approved a labeling update for the injectable LDL-lowering agent inclisiran that expands its indications to include primary prevention for patients with elevated LDL cholesterol.
Baca lebih lajut »
U.S. FDA classifies recall of J&J's electrosurgical tools as most seriousThe U.S. Food and Drug Administration (FDA) on Tuesday classified the recall of certain electrosurgery tools manufactured by a Johnson & Johnson unit as the most serious, saying their use could lead to injuries or death.
Baca lebih lajut »
FDA Approves Cognitive Behavioral App for Adults With T2DA smartphone app that delivers cognitive behavioral therapy to adults with type 2 diabetes received US FDA marketing approval on July 10, with prescribing and sales slated to start later in 2023.
Baca lebih lajut »
FDA Clears the Tandem Mobi Insulin PumpApproved for people with diabetes aged 6 years or older, the pump works with a continuous glucose monitor in a hybrid closed-loop system.
Baca lebih lajut »
FDA Approves New Device for Enlarged Prostate TreatmentThe FDA has approved a new catheter designed to treat urinary tract symptoms of an enlarged prostate, also known as benign prostate hyperplasia.
Baca lebih lajut »